Uzma Haque is a Rheumatology/Immunology physician affiliated with Johns Hopkins University. OpenAlex indexes 46 publications with 1,973 citations (h-index 16); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4940 Eastern Avenue
Baltimore, MD 212870001
Telephone
410-550-2400Registry record last updated 7 Feb 2013.
Clinical trials
- Treatment of Vitamin D Deficiency in Patients With Rheumatoid Arthritis
Sponsor: Johns Hopkins University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
56.2%Folate Analog Metabolic Inhibitor25.1%Methotrexate100%Part D≥59 patientsTNF inhibitor16.2%Enbrel Sureclick47%Humira(Cf) Pen24%Simponi16%Humira(Cf)13%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
21.9%Corticosteroid14.2%Prednisone100%Part D≥41 patientsAminosalicylate4.2%Sulfasalazine100%Part D≥14 patients+ 1 more class in this area
Antiparasitic
12.2%Antimalarial12.2%Hydroxychloroquine Sulfate100%Part D≥32 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Tanguy Seiwert, MD
Johns Hopkins University
Evan Lipson, MD
Johns Hopkins University
Pradeep Ramulu, MD
Johns Hopkins University
Nicholas Maragakis, MD
Johns Hopkins University
Marc Hochberg, MD
University of Maryland School of Medicine
Michelle Petri, MD
Johns Hopkins University School of Medicine
Dinesh Khanna, MD
University of Michigan
Matthew Liang, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”